Viewing data from:

BACLOFEN

ANDA

BACLOFEN | A209102 | RUBICON RESEARCH LTD

4 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 16 NDCs

Highest NADAC/Unit

$1.76

per ea

Lowest NADAC/Unit

$0.0332

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
52817031810BACLOFEN 15 MG TABLET	$1.76	EA	Generic	—	2026-06-17
72888000901BACLOFEN 5 MG TABLET	$0.0632	EA	Generic	—	2026-06-17
52817031910BACLOFEN 5 MG TABLET	$0.0632	EA	Generic	—	2026-06-17
52817032150BACLOFEN 20 MG TABLET	$0.0552	EA	Generic	—	2026-06-17
72888001100BACLOFEN 20 MG TABLET	$0.0552	EA	Generic	—	2026-06-17
72888001101BACLOFEN 20 MG TABLET	$0.0552	EA	Generic	—	2026-06-17

Showing 6 of 16 NDCs.

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 4 NDCs (4 FSS)

Lowest Price

$5.65

Highest Price

$21.01

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
72789-0478-01BACLOFEN 5MG TAB	$5.65	FSS	PD-Rx Pharmaceuticals, Inc.	05/31/2026
72789-0479-01BACLOFEN 10MG TAB	$5.65	FSS	PD-Rx Pharmaceuticals, Inc.	05/31/2026
72789-0479-95BACLOFEN 10MG TAB	$21.01	FSS	PD-Rx Pharmaceuticals, Inc.	05/31/2026
72789-0480-01BACLOFEN 20MG TAB	$6.45	FSS	PD-Rx Pharmaceuticals, Inc.	05/31/2026

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain12 active DMFs6 inactive

11 active API suppliers hold Drug Master Files for this ingredient.

FINE CHEMICALS CORP PTY LTDBACLOFEN

DMF 64211986

PCASBACLOFEN

DMF 70771987

EXCELLA GMBH AND CO KGBACLOFEN

DMF 73111988

ZAKLADY FARMACEUTYCZNE POLPHARMA SABACLOFEN

DMF 180142005

MATRIX PHARMACORP PRIVATE LTDBACLOFEN USP

DMF 182202005

PIRAMAL PHARMA LTDBACLOFEN

DMF 284552014

UNICHEM LABORATORIES LTDBACLOFEN USP

DMF 324312018

COHANCE LIFESCIENCES LTDBACLOFEN USP

DMF 333022018

FINE CHEMICALS CORP PTY LTDBACLOFEN (PROCESS 2)

DMF 352242020

MEDILUX LABORATORIES PVT LTDBACLOFEN

DMF 356542021

MANKIND PHARMA LTDBACLOFEN USP

DMF 370112022

VIYASH LIFE SCIENCES PRIVATE LTDBACLOFEN USP

DMF 385322023

RESOLUTION CHEMICALS LTDInactiveBACLOFEN

DMF 73681988

ICFI SPAInactiveBACLOFEN

DMF 74991988

RESOLUTION CHEMICALS LTDInactiveBACLOFEN RAW MATERIAL

DMF 77241988

ERREGIERRE SPAInactiveBACLOFEN

DMF 78171988

RESOLUTION CHEMICALS LTDInactiveBACLOFEN

DMF 98371992

PFC ITALIANA SRL DIV ALFA CHEMICALS ITALIANAInactiveBACLOFEN

DMF 124381997

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Dec 18, 2017	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (4)

Sort:

#001 — 5MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Nov 28, 2017

No patent or exclusivity listings for this strength.

#002 — 10MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Nov 28, 2017

#003 — 20MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Nov 28, 2017

#004 — 15MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Feb 5, 2024